| Title |
Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy
|
|---|---|
| Published in |
Cochrane database of systematic reviews, March 2015
|
| DOI | 10.1002/14651858.cd003217.pub5 |
| Pubmed ID | |
| Authors |
T Umapathi, Richard AC Hughes, Eduardo Nobile‐Orazio, Jean‐Marc Léger |
| Abstract |
Multifocal motor neuropathy (MMN) is characterised by progressive, predominantly distal, asymmetrical limb weakness and usually multiple partial motor nerve conduction blocks. Intravenous immunoglobulin (IVIg) is beneficial but the role of immunosuppressive agents is uncertain. This is an update of a review first published in 2002 and previously updated in 2003, 2005, 2008 and 2011. |
Mendeley readers
The data shown below were compiled from readership statistics for 141 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 141 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 19 | 13% |
| Student > Master | 18 | 13% |
| Researcher | 16 | 11% |
| Student > Ph. D. Student | 11 | 8% |
| Student > Doctoral Student | 8 | 6% |
| Other | 24 | 17% |
| Unknown | 45 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 45 | 32% |
| Nursing and Health Professions | 11 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 4% |
| Neuroscience | 6 | 4% |
| Agricultural and Biological Sciences | 4 | 3% |
| Other | 17 | 12% |
| Unknown | 52 | 37% |